Iron­wood's lay­offs; Sh­iono­gi’s RSV pill suc­ceeds in Phase 2

Plus, news about Im­munome, Deer­field, Switch Ther­a­peu­tics, Re­Code Ther­a­peu­tics, Atara Bio­ther­a­peu­tics and Gen­fit:

Iron­wood halves work­force: The Boston drug­mak­er is let­ting go of about …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER